title: Intravitreal steroid versus macular laser for treatment of diabetic macular edema.
abstract: Diabetic macular edema is a leading cause of vision loss in the United States. Focal/grid laser photocoagulation has been the gold standard for treatment over the past two decades. Intravitreal pharmacologic treatments increasingly have been used over the past 5 years. Various studies have shown the possible benefits of intravitreal corticosteroids and anti-vascular endothelial growth factors in the treatment of diabetic macular edema. However, focal/grid laser photocoagulation continues to be the only proven safe and effective treatment for diabetic macular edema.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Gunther
authors.forename: Michael
authors.initials: M
authors.lastname: Ip
mesh_terms: D003930:Diabetic Retinopathy / Q000150:complications* / Q000188:drug therapy*; D004333:Drug Administration Routes; D006801:Humans; D007834:Lasers; D008269:Macular Edema / Q000150:complications* / Q000188:drug therapy*; D013256:Steroids / Q000008:administration & dosage* / Q000627:therapeutic use*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D013256:Steroids; D042461:Vascular Endothelial Growth Factor A